MedTrace Logo

Caffeine Versus Placebo for Spinal Headaches

NCT00809627 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-08-15

No results posted yet for this study

Summary

Caffeine will be studied against placebo in patients with positional headache after a lumbar puncture (aka "spinal headache").

Conditions

  • Post Dural Puncture Headache

Interventions

DRUG

Caffeine

Caffeine 500 mg IV

DRUG

saline

Normal saline

Sponsors & Collaborators

  • United States Naval Medical Center, Portsmouth

    lead FED

Principal Investigators

  • Mark A Kostic, MD · United States Naval Medical Center, Portsmouth

  • Marcelo Darabos, MD · United States Naval Medical Center, Portsmouth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00809627 on ClinicalTrials.gov